Cancer Australia has established the Priority-driven Collaborative Cancer Research Scheme to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.
Overview
The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia.
This funding scheme helps to:
- coordinate funding of priority-driven cancer research at the national level,
- foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
- foster consumer participation in cancer research, from design to implementation.
Working with the National Health and Medical Research Council (NHMRC)
This research scheme is managed by Cancer Australia and the agency collaborates with NHMRC in this grant scheme. NHMRC facilitates registration and initial assessment of applications, and endorses grants funded through this scheme in recognition of their scientific merit.
Successful applicants in the 2022 Round
On 15 December 2022, the Australian Government announced successful applicants in the 2022 round of the Priority-driven Collaborative Cancer Research Scheme, proudly supported by Cancer Australia, Australian Lions Childhood Cancer Research Foundation, Can Too Foundation, Leukaemia Foundation, Lung Foundation Australia, My Room Children’s Cancer Charity Ltd, and The Kids’ Cancer Project.
Successful grants in the 2022 PdCCRS round are as follows:
Aoude, Lauren
Diamantina Institute, The University of Queensland
Radiomics analysis to improve outcomes for melanoma patients
Funded by: Cancer Australia
Brims, Fraser
Curtin University
Improving lung cancer care: the lung cancer clinical quality data platform (LUCAP)
Funded by: Cancer Australia and Lung Foundation Australia
Da Gama Duarte, Jessica
Olivia Newton-John Cancer Research Institute, La Trobe University
Early detection, diagnosis, and prognosis of lung cancers
Funded by: Cancer Australia and Lung Foundation Australia
Gargett, Tessa
Royal Adelaide Hospital, Central Adelaide Local Health Network Incorporated
Targeting the DC-T cell axis to treat glioblastoma
Funded by: Cancer Australia and The Kids’ Cancer Project
Gunawardana, Jithendra
Translational Research Institute, The University of Queensland
Harnessing the tumour microenvironment to stratify and treat nodular lymphocyte predominant Hodgkin Lymphoma
Funded by: Leukaemia Foundation
Lawrence, Mitchell
Monash University
Boosting PSMA levels in prostate cancer
Funded by: Cancer Australia
Panagopoulos, Vasilios
The University of Adelaide
Targeted inhibition of myeloperoxidase (MPO): A new therapeutic strategy to prevent multiple myeloma disease progression
Funded by: Cancer Australia, Can Too Foundation, and Leukaemia Foundation
Parker, Amelia
Garvan Institute of Medical Research, University of New South Wales
Targeting the CTHRC1-Wnt axis as a precision medicine approach in squamous lung cancer
Funded by: Cancer Australia
Sieber, Oliver
The Walter and Eliza Hall Institute of Medical Research
Personalising first-line treatment for patients with metastatic colorectal cancer
Funded by: Cancer Australia
Somers, Klaartje
Children’s Cancer Institute, University of New South Wales
Targeting NAD metabolism to overcome therapeutic resistance in adult and paediatric acute myeloid leukaemia
Funded by: Cancer Australia, Australian Lions Childhood Cancer Research Foundation, My Room Children’s Cancer Charity Limited, and The Kids’ Cancer Project
Tobin, Joshua
Mater Research Institute, The University of Queensland
The Role of Lipids in the Immune Fitness of Malignant B cells, Intratumoral T cells and CAR-T cells in Follicular Lymphoma
Funded by: Cancer Australia and Can Too Foundation
Webb, Penelope
The Council of the Queensland Institute of Medical Research
Linking routine health data to investigate variation and inequality in care and survival to Improve outcomes for women with cervical, uterine, vaginal and vulvar cancer in Australia
Funded by: Cancer Australia
Yim, Howard Chi Ho
Microbiome Research Centre, University of New South Wales
A Novel Probiotic as a preventive strategy for Colorectal Neoplasia
Funded by: Cancer Australia
Cancer Australia's funding partners and the successful applicants in the PdCCRS rounds of:
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007